Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9


[The role of the family in adolescents' subjective well-being].

Lampropoulou A.

Psychiatriki. 2018 Apr-Jun;29(2):172-182. doi: 10.22365/jpsych.2018.292.172. Greek, Modern.


Personality, school, and family: What is their role in adolescents' subjective well-being.

Lampropoulou A.

J Adolesc. 2018 Aug;67:12-21. doi: 10.1016/j.adolescence.2018.05.013. Epub 2018 Jun 2.


VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation.

Fantin A, Lampropoulou A, Senatore V, Brash JT, Prahst C, Lange CA, Liyanage SE, Raimondi C, Bainbridge JW, Augustin HG, Ruhrberg C.

J Exp Med. 2017 Apr 3;214(4):1049-1064. doi: 10.1084/jem.20160311. Epub 2017 Mar 13.


Increased Expression of Serglycin in Specific Carcinomas and Aggressive Cancer Cell Lines.

Korpetinou A, Papachristou DJ, Lampropoulou A, Bouris P, Labropoulou VT, Noulas A, Karamanos NK, Theocharis AD.

Biomed Res Int. 2015;2015:690721. doi: 10.1155/2015/690721. Epub 2015 Oct 25.


Epidermal growth factor receptor status and Notch inhibition in non-small cell lung cancer cells.

Giannopoulou E, Nikolakopoulos A, Kotsirilou D, Lampropoulou A, Raftopoulou S, Papadimitriou E, Theocharis AD, Makatsoris T, Fasseas K, Kalofonos HP.

J Biomed Sci. 2015 Oct 24;22:98. doi: 10.1186/s12929-015-0196-1.


NRP1 Regulates CDC42 Activation to Promote Filopodia Formation in Endothelial Tip Cells.

Fantin A, Lampropoulou A, Gestri G, Raimondi C, Senatore V, Zachary I, Ruhrberg C.

Cell Rep. 2015 Jun 16;11(10):1577-90. doi: 10.1016/j.celrep.2015.05.018. Epub 2015 Jun 4. Erratum in: Cell Rep. 2015 Dec 1;13(9):2037.


Neuropilin regulation of angiogenesis.

Lampropoulou A, Ruhrberg C.

Biochem Soc Trans. 2014 Dec;42(6):1623-8. doi: 10.1042/BST20140244. Review.


Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells.

Raimondi C, Fantin A, Lampropoulou A, Denti L, Chikh A, Ruhrberg C.

J Exp Med. 2014 Jun 2;211(6):1167-83. doi: 10.1084/jem.20132330. Epub 2014 May 26.


Pharmacodynamic and pharmacokinetic analysis of apoE4 [L261A, W264A, F265A, L268A, V269A], a recombinant apolipoprotein E variant with improved biological properties.

Lampropoulou A, Zannis VI, Kypreos KE.

Biochem Pharmacol. 2012 Dec 1;84(11):1451-8. doi: 10.1016/j.bcp.2012.09.006. Epub 2012 Sep 14.


Supplemental Content

Loading ...
Support Center